Humanin is an endogenous activator of chaperone-mediated autophagy.
Gong. Zhenwei Z; Tasset. Inmaculada I; Diaz. Antonio A; Anguiano. Jaime J; Tas. Emir E; Cui. Lingguang L; Kuliawat. Regina R; Liu. Honghai H; Kühn. Bernhard B; Cuervo. Ana Maria AM; Muzumdar. Radhika R
Key Findings
- Humanin directly activates chaperone-mediated autophagy (CMA) by enhancing substrate binding and entry into lysosomes.
- The HNG analogue protects fibroblasts, heart cells, and neurons from stress‑induced death, and this protection is lost in CMA‑deficient cells.
- Humanin interacts with HSP90 on the lysosomal membrane; blocking HSP90 stops the protective effect.
Practical Outcomes
- Humanin (or its more potent HNG version) could be explored as a supplement to boost CMA, a cellular recycling pathway linked to longevity and stress resistance. Biohackers might consider low‑dose trials while awaiting human safety and dosing data, and should monitor markers of cellular stress and autophagy if possible.
Summary
The study shows that the naturally occurring peptide humanin can turn on a cell-cleanup system called chaperone-mediated autophagy, which helps protect heart, brain and other cells from stress. A stronger version, HNG, works the same way, but the benefit disappears if that cleanup system is blocked.
Abstract
Chaperone-mediated autophagy (CMA) serves as quality control during stress conditions through selective degradation of cytosolic proteins in lysosomes. Humanin (HN) is a mitochondria-associated peptide that offers cytoprotective, cardioprotective, and neuroprotective effects in vivo and in vitro. In this study, we demonstrate that HN directly activates CMA by increasing substrate binding and translocation into lysosomes. The potent HN analogue HNG protects from stressor-induced cell death in fibroblasts, cardiomyoblasts, neuronal cells, and primary cardiomyocytes. The protective effects are lost in CMA-deficient cells, suggesting that they are mediated through the activation of CMA. We identified that a fraction of endogenous HN is present at the cytosolic side of the lysosomal membrane, where it interacts with heat shock protein 90 (HSP90) and stabilizes binding of this chaperone to CMA substrates as they bind to the membrane. Inhibition of HSP90 blocks the effect of HNG on substrate translocation and abolishes the cytoprotective effects. Our study provides a novel mechanism by which HN exerts its cardioprotective and neuroprotective effects.
Study Information
pubmed
2017
2017-11-29T00:00:00.000Z
10.1083/jcb.201606095
79
45